Mechanistic aspects of mineralocorticoid receptor activation. scribed: the unliganded form (apo receptor) of the reti-Aldosterone exerts its biological effects through binding to noid X receptor ␣ (RXR␣) and (thiazolidinedione)-permineralocorticoid receptor (MR). Ligand binding induces a oxisome proliferator-activated receptor ␥ (PPAR␥) and receptor transconformation within the ligand-binding domain the agonist-bound form (holo receptor) of all-trans-reti-
and dissociation of associated proteins from the receptor. The ligand-activated receptor binds as a dimer to the response noic acid receptor ␥ (RAR␥), thyroid receptor ␣ (TR␣), elements present in the promoter region of target genes and estrogen receptor ␣ (ER␣), progesterone receptor (PR), initiates the transcription through specific interactions with the and PPAR␥ [5] [6] [7] [8] [9] [10] [11] . All of these NR LBDs have a comtranscription machinery. The glucocorticoid hormone cortisol mon fold, with 11 to 12 ␣ helices (numbered H1 through binds to the human MR (hMR) with the same affinity as aldosterone, but is less efficient than aldosterone in stimulating the H12) and one ␤ turn arranged as an antiparallel ␣ helical hMR transactivation. The antimineralocorticoid spirolactones "sandwich" in a three-layer structure [12] . The LBD also bind to the hMR but induce a receptor conformation that adopts a more compact structure when a ligand is bound. is transcriptionally silent. In this report, we describe the key residues involved in the recognition of agonist and antagonist The helix H11 is repositioned in continuity with H10, ligands and propose a two-step model with a dynamic dimenand helix H12, which encompasses the autonomous actision for the MR activation. In its unliganded state, MR is in an vating domain (AF-2AD), is folded back toward the opened conformation in which folding into the ligand-binding LBD core. The repositioning of H12, together with addicompetent state requires both the heat shock protein 90 and the C-terminal part of the receptor. An intermediate complex tional structural changes, such as bending of H3, brings is generated by ligand binding, leading to a more compact it into a distinct receptor environment, creating an interreceptor conformation. This transient complex is then conface suitable for NR coactivator binding [13] . Many coverted to a transcriptionally active conformation in which staactivators that interact with the NRs in a ligand-depenbility depends on the steroid-receptor contacts. dent manner have been identified. These include steroid receptor-coactivator 1 (SRC-1), transcriptional interme-Aldosterone acts via a ligand-activated transcription diary factor II (TIF-II)/GRIP-1, receptor-interacting factor, the mineralocorticoid receptor (MR). The MR is proteins of molecular weights 140 (RIP-140), TIF-1, and a member of the nuclear receptor (NR) family that in-CBP/p300 [14, 15] . cludes receptors for steroid and thyroid hormones, vita-
The aldosterone-dependent activation of gene tranmin D 3 , and retinoic acids, as well as numerous orphan scription is thought to be a multistep process. Aldostereceptors for which no ligands are known [1] [2] [3] [4] . MR has rone initially binds to MR and causes a receptor transa modular structure comprising five regions (A through conformation within the LBD that is believed to lead E; Fig. 1 ). The N-terminal A/B region harbors an autonoto the dissociation of the associated proteins from the mous activation function. The central C-domain (DBD) receptor [16, 17] . The ligand-activated receptor then is highly conserved and is composed of two zinc fingers binds, as a dimer, to the response elements in the proinvolved in DNA binding and receptor dimerization. A moter regions of target genes and initiates hormonehydrophilic region forms a hinge between the DBD and mediated transcription through specific interactions with C-terminal ligand-binding domain (LBD). The LBD methe transcription machinery [18] [19] [20] . The way in which diates numerous functions, including ligand binding, inaldosterone acts through its own receptor has been a teraction with heat-shock proteins, dimerization, nuclear targeting, and hormone-dependent activation. puzzle for some time for two main reasons: aldosterone Several crystal structures of NR LBDs have been deand cortisol both bind to the human MR (hMR) with the same affinity, and the plasma glucocorticoid concentration is 100-to 1000-fold higher than that of aldosterone. Consequently, most of the hMR should be occupied by glucocorticoid, resulting in sodium retention. into 11-keto derivatives (cortisone and 11-dehydrocorticosterone) that have a very low affinity for the MR [23] . This enzyme is present in aldosterone-sensitive tissues [24, 25] , and mutations that inactivate this enzyme are and MR734-984 both have a lower affinity for aldosteresponsible for the syndrome of apparent mineralocortirone than the entire receptor (Table 1) . MR611-984, coid excess, resulting in sodium retention and severe which is devoid of the A/B region, has an affinity similar arterial hypertension [26] . Ex vivo experiments have reto that of the entire hMR (Table 1) . Thus, the sequence vealed that the MR is more sensitive to aldosterone than Thr-Ile-Ser-Arg-Ala (729 through 733) upstream of the to cortisol [27] [28] [29] [30] [31] . However, the mechanisms by which LBD is required for hsp90 and steroid binding, and a MR is differentially stimulated by the two corticosteroid longer sequence is needed for folding the receptor into hormones remain unknown. a high-affinity hormone-binding state. The antimineralocorticoid spirolactones, synthetic ste-Short segments of the C-terminal part of the receptor roids with a C17 ␥-lactone ring, have been used for the were deleted because large truncations completely abolpast 30 years in the treatment of sodium-retaining states ished its steroid-binding capacity. These mutant hMRs and as antihypertensive agents [32, 33] . Mineralocorti-[MR⌬(C1), MR⌬(C2), MR⌬(C3), and MR⌬(C4)] lack coid antagonists bind to the receptor with an affinity the last one, two, three, or four amino acids [38] . Deletion identical to that of aldosterone and induce a receptor of the last one or two amino acids decreases aldosterone conformation that is transcriptionally silent [17] . and cortisol binding by 30%, as well as the binding of In this report, we studied ligand-hMR interactions by antagonists such as RU26752. Deletion of the last three using a three-dimensional model of the hMR-LBD [34], amino acids [MR⌬(C3)] resulted in a 70% decrease in and analyzed the hMR activation process by examining steroid binding, and deletion of the last four amino acids the ligand-induced hMR conformational changes and the abolishes the steroid binding, although the interaction receptor-coactivator interaction.
with hsp90 is not affected. The lack of ligand binding to the carboxy-terminal truncated hMRs was due to mis-
FOLDING REQUIREMENTS OF hMR FOR
folding of the receptor, as shown by the different sensitiv-LIGAND BINDING ity to trypsin of MR⌬(C4) when compared with that of On the basis of sequence homology among NRs, the the full-length receptor. These results support the idea hMR-LBD has been defined as the sequence from posithat a short sequence upstream the LBD is necessary tion 734 to 984 [27] . However, this sequence has not been for the interaction of hMR with hsp90, and that hsp90 shown to be the minimum region that can bind agonists and the C terminus of hMR are both essential for folding and antagonists. A series of mutant hMRs truncated at of the receptor into a ligand-binding competent state. either the amino-or carboxy-terminal end of the receptor was analyzed for its ability to bind agonists and antag-IDENTIFICATION OF hMR AMINO ACIDS onists and to interact with the heat shock protein hsp90, INTERACTING WITH MINERALOCORTICOID a chaperone protein that is a prerequisite for ligand bind-AGONISTS AND ANTAGONISTS ing to hMR [35] [36] [37] . The MR-LBD (MR734-984) does
The crystal structure of the LBD of several NRs has not interact with hsp90 and has a lower aldosteroneshown a common fold with 11 to 12 ␣ helices and one binding capacity than the entire receptor (Table 1) . Add-␤ turn arranged as an antiparallel ␣ helical "sandwich" ing a short amino acid sequence, the five residues upin a three-layer structure [12] . As MR purification and stream of the LBD, led to a truncated receptor (MR729crystallization appeared to be very difficult, a three-dimen-984) that interacts with hsp90 and has the same aldosterone-binding capacity as the entire hMR. MR729-984 sional model of the hMR-LBD has been constructed by the two polar extremities of aldosterone (the C3-ketone group on the A-ring on one hand and the C20-ketone and the C21-hydroxyl on the other hand). We replaced polar residues of the ligand-binding pocket by alanine onists. Within the site II, Asn770 and Thr945 interact with the 17 ␤-substituent of corticosteroids. Asn770 makes and tested the ability of the mutant hMRs (N770A, Q776A, R817A, and T945A) to interact with steroids a hydrogen bond with the C21-hydroxyl group and the 18-hemiketal group, and the Thr945 ␥ methyl group is selected for their agonist (aldosterone, cortisol) or antagonist (progesterone) properties and for their structures in a Van der Waals contact with the C21-hydroxyl group. Thus, the agonist-hMR interaction is characterized by (Fig. 2) . Aldosterone, cortisol, and progesterone have the C3 ketone group in common. Aldosterone and corti-numerous contacts within the anchoring site II compared with the antagonist-hMR interaction. sol are characterized by a C21 hydroxyl group, whereas progesterone is lacking this hydroxyl group. Q776A and N770A, Q776A, and R817A were tested, by cotransfection assays, for their ability to respond to aldosterone R817A display a lower affinity for aldosterone, cortisol, and progesterone compared with the wild-type hMR and cortisol. At a concentration of 10 Ϫ6 mol/L, cortisol was unable to stimulate the transactivation function of ( Table 2) . Progesterone binds to T945A and N770A with an affinity similar to that of the wild-type hMR. In con-N770A, Q776A, and R817A, whereas at this concentration, it maximally stimulated the wild-type hMR function trast, substitution of Thr945 by alanine decreased the affinity of the receptor for aldosterone and cortisol, and (Fig. 3) . Aldosterone was unable to stimulate the transactivation of N770A. In contrast, the aldosterone in-replacement of Asn770 by alanine completely abolished the ability of hMR to bind aldosterone and cortisol.
duced-transactivation activities of Q776A and R817A were 25 and 75% that of the wild-type receptor, respec-These results altogether support the proposal that site I and site II anchor the A-ring and D-ring, respectively.
tively. These results are compatible with steroid-docking studies that revealed that cortisol underwent an approxi-Within the site I, Gln776 and Arg817 interact with the steroid C3-ketone group, common to agonists and antag-mate 40Њ rotation around its C3-C17 axis within the li- Fig. 3 . Transcriptional activation of luciferase activity by wild-type and mutant hMRs. COS-7 cells were transfected with wild-type or mutant-hMR expression vectors, pFC31luc as the reporter plasmid, and a ␤-galactosidase internal reporter to correct for transfection efficiency. Before harvesting, cells were treated for 24 hours with 10 Ϫ6 mol/L aldosterone () or cortisol ( ). Transactivation was determined by luciferase activity, normalized to the internal ␤-galactosidase control, and expressed as a percentage of wild-type activity at 10 Ϫ6 mol/L. Each point is the mean Ϯ SEM of three separate experiments. analysis. The lysate was then divided into two. One sample was kept at 20ЊC to measure the stability of steroid-binding sites, and the other was incubated with 1 mol/L unlabeled aldosterone, cortisol, or RU26752.
hMR ACTIVATION PROCESS
Bound and free steroids were separated by dextran charcoal. Nonspecific binding was measured in parallel incubations for each incubation
The structure of the LBD of several NRs has been time. Results are corrected for receptor stability and are expressed as described [5] [6] [7] [8] [9] [10] [11] . The major difference between the unlia percentage of the binding measured at zero time.
ganded and agonist-associated structures is the repositioning of the helix H12 that is folded back toward the LBD core in the agonist-associated conformation, creatwith the backbone oxygen atom of Glu955, a residue of ing an interface suitable for NR coactivator binding [13] .
the H11-H12 loop. The disrupting or loosening antago-As some distinct contacts are involved in the interaction nist-receptor contacts probably destabilize helix H12 of MR with agonists and antagonists, we wondered how from its active position. these distinct contacts modulate the hMR activity.
It is worth emphasizing that glucocorticoids, such as Aldosterone antagonists, such as progesterone and cortisol and dexamethasone, exhibit an affinity for hMR RU26752, bind to hMR with an affinity of the same order of the same order of magnitude as aldosterone (Table of magnitude as that of aldosterone. Nevertheless, they 2, data not shown for dexamethasone). Nevertheless, dissociate more rapidly from the receptor than does aldothey dissociate more rapidly from the hMR than aldostesterone, indicating that antagonist-hMR complexes are rone, a result illustrated in Figure 4 for cortisol. On the less stable than aldosterone-hMR complexes ( Table 2 other hand, cis-trans-cotransfection assays revealed that and Fig. 4 ). Proteolysis assays revealed that both agonist hMR was more sensitive to aldosterone than to cortisol and antagonist binding to hMR induced changes in the and dexamethasone [27] [28] [29] [30] [31] . The differences in the abil-LBD compaction [17] . Glutathione S transferase (GST) ity of aldosterone and cortisol to stimulate hMR transpull-down experiments showed that agonist-associated activation function are probably due to the distinct con-hMRs, but not unliganded or antagonist-associated hMR, tacts involved in the interaction of hMR with aldosterone are able to interact with RIP140, SRC1, and TIF-1␣, and cortisol. In fact, in addition to the 21 hydroxyl group three coactivators known to bind to NRs. present in both steroids, aldosterone is characterized by We propose that interactions between mineralocortian 11-18 hemiketal group and cortisol by the 11␤-and coid agonists and hMR, especially between the C21-hy-17␣-hydroxyl groups. droxyl group and the residues Asn770 and Thr945, are
In conclusion, we propose that the hMR activation crucial for the stabilization of the helix H12 in its active state. The homology model revealed that the amide is a multistep process with a dynamic dimension. An equilibrium model for hMR activation is proposed in group of the Asn770 residue makes a hydrogen bond In the absence of hormone, the hMR exists in a transcriptionally inactive conformation. After agonist binding, the receptor is converted to a transient inactive conformation and then to a transcriptionally active conformation. The contacts between the hMR and aldosterone in the helix H12 region stabilize hMR in its active conformation. After antagonist binding, the receptor adopts the transient inactive conformation. The loss of contacts between hMR and antagonists prevents the stabilization of H12 in its active position. 
